NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat

Journal of Neurotrauma

Volumn 24, Issue 4, 2007, Pages 732-744

  Germanò, Antonino ^a   Caffo, Mariella ^a   Angileri, Filippo Flavio ^a   Arcadi, Francesca ^b   Newcomb Fernandez, Jennifer ^c   Caruso, Gerardo ^a   Meli, Francesco ^f   Pineda, Jose A ^g   Lewis, Stephen B ^d   Wang, Kevin K W ^d,e   Bramanti, Placido ^b   Costa, Chiara ^a   Hayes, Ronald L ^d,e  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c Newcomb Scientific LLC   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF PALERMO   (Italy)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral deficits; Blood brain barrier; Cognitive deficits; Felbamate; NMdA receptor; Subarachnoid hemorrhage

Indexed keywords

EVANS BLUE; FELBAMATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; CARBAMIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; PROPANEDIOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEAM BALANCE TEST; BEHAVIOR DISORDER; BLOOD BRAIN BARRIER; BODY WEIGHT; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN STEM; CEREBELLUM; CISTERNA MAGNA; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EXCITOTOXICITY; EXTRAVASATION; GRAY MATTER; MALE; MEMBRANE PERMEABILITY; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SCORING SYSTEM; SPECTROFLUOROMETRY; SPRAGUE DAWLEY RAT; SUBARACHNOID HEMORRHAGE; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; BODY EQUILIBRIUM; BRAIN CIRCULATION; DRUG ANTAGONISM; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BODY WEIGHT; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EVANS BLUE; MALE; MICROCIRCULATION; MUSCULOSKELETAL EQUILIBRIUM; NEUROPROTECTIVE AGENTS; PHENYLCARBAMATES; PROPYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SPECTROMETRY, FLUORESCENCE; SUBARACHNOID HEMORRHAGE;

EID: 34249849556     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.0181     Document Type: Article

References (75)

1. ADUSUMALLI, V.E., YANG, J.T., WONG, K.K., et al. (1991). Felbamate pharmacokinetics in the rat, rabbit, and dog. Drug Metab. Dispos. 19, 1116-1125.
2. ARCADI, F.A., IMPERATORE, C., LO PRESTI, R., et al. (1997). Neuroprotective activity of felbamate following transient forebrain ischemia in the gerbil. Trends Neurosci. 20, 39-40.
3. D'AVELLA, D., GERMANO, A., SANTORO, G., et al. (1990). Effects of experimental subarachnoid hemorrhage on CSF eicosanoids in the rat. J. Neurotrauma 7, 121-129.
4. D'AVELLA, D., ZUCCARELLO, M., and TOMASELLO, F. (1993). Protective effect of U-78157G on local cerebral glucose utilization in the acute stage following subarachnoid hemorrhage (SAH), in: Cerebral Vasospasm, J.M. Findlay (ed), Elsevier Science Publishers B.V.: Amsterdam, pps. 427-430.
5. D'AVELLA, D., GERMANO, A., and TOMASELLO, F. (1994). Early blood-brain barrier changes after experimental subarachnoid haemorrhage: a quantitative and electron microscopy study, in: New Trends in Management of Cerebrovascular Malformations. A. Pasqualin and R. Da Pian (eds), Springer-Verlag: New York, pps. 48-51.
6. D'AVELLA, D., CICCIARELLO, R., ZUCCARELLO, M., et al. (1996). Brain energy metabolism in the acute stage of experimental subarachnoid haemorrhage: local changes in cerebral glucose utilization. Acta Neurochir. (Wien). 138, 737-744.
7. DELGADO, T.J., BRISMAR, J., and SVENDGAARD, N.A. (1985). Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16, 595-605.
8. DELGADO, T.J., ARBAB, M.A., DIEMER, N.H., et al. (1986). Subarachnoid haemorrhage in the rat: cerebral blood flow and glucose metabolism during the late phase of cerebral vasospasm. J. Cereb. Blood Flow Metab. 6, 590-599.
9. DIETRICH, W.D., ALONSO, O., HALLEY, M., et al. (1992). Intraventricular infusion of N-methyl-D-aspartate. Acute blood-brain barrier consequences. Acta Neuropathol. 84, 621-629.
10. DOCZI, T. (1985). The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid hemorrhage. Clinical and experimental studies. Acta Neurochir. (Wien.) 77, 110-132.
11. DOCZI, T., JOO, F., ADAM G., et al. (1986). Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery 18, 733-739.
12. ENBLAD, P., VALTYSSON, J., ANDERSSON, J., et al. (1996). Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 16, 637-644.
13. FEENEY, D.M., GONZALEZ, A., and LAW, W.A. (1982). Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science 271, 855-877.
14. FENSTERMACHER, J.D., and RAPAPORT, S.I. (1984). Blood-brain barrier, in: E.M. Renkin, and C.C. Michel (eds), Handbook of Physiology, Vol 4: The Cardiovascular System. Bethesda, MD: American Physiological Society, pps. 969-1000.
15. GERMANO, A., D'AVELLA, D., CICCIARELLO, R., et al. (1992). Blood-brain barrier permeability changes after experimental subarachnoid hemorrhage. Neurosurgery 30, 882-886.
16. GERMANO, A., DIXON, E., D'AVELLA, D., et al. (1994). Behavioural deficits following experimental subarachnoid hemorrhage in the rat. J. Neurotrauma 11, 345-353.
17. GERMANO, A., TISANO, A., RAFFAELE, M., et al. (1997). Is there a group of early aneurysm surgery patients who can expect to achieve a complete long-term neuropsychological recovery? Acta Neurochir. 139, 507-514.
18. GERMANO, A., CARUSO, G., CAFFO, M., et al. (1998a). Does subarachnoid hemorrhage per se induce long-term neuropsychological and cognitive alterations? Acta Neurochir. 140, 805-812.
19. GERMANO, A., IMPERATORE, C., D'AVELLA, D., et al. (1998b). Antivasospastic and brain protective effects of a hydroxyl radical scavenger (AVS) on cerebral vasospasm and BBB permeability changes after experimental SAH. J. Neurosurg. 88, 1075-1081.
20. GERMANO, A., D'AVELLA, D., IMPERATORE, C., et al. (2000). Time course of blood-brain barrier permeability changes after experimental subarachnoid hemorrhage. Acta Neurochir. 142, 575-581.
21. GERMANO, A., COSTA, C., DEFORD, S.M., et al. (2002). Systemic administration of a calpain inhibitor reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J. Neurotrauma 19, 887-896.
22. GORGULU, A., KINS, T., COBANOGLU, S., et al. (2000). Reduction of edema and infarction by memantine and MK-801 after focal cerebral ischaemia and reperfusion in the rat. Acta Neurochir. 142, 1287-1292.
23. GOTOH, O., KOIDE, T., ASANO, T. et al. (1984). A model to study ischemic brain edema in rats and the influence of drugs, in: Recent Progress in the Study and Therapy of Brain Edema, K.G. Go and A. Baethmann (eds), Plenum: New York, pps. 499-508.
24. GRAVES, N.M., LUDDEN, T.M., HOLMES, G.B., et al. (1989). Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modelling to clinical trials. Pharmacotherapy 9, 372-376.
25. GULES, I., SATOH, M., NANDA, A., et al. (2003). Apoptosis, blood-brain barrier, and subarachnoid hemorrhage. Acta Neurochir. Suppl. 86, 483-487.
26. HUTCHINSON, P.J., AL-RAWI, P.G., O'CONNELL, M.T., et al. (2000). Biochemical changes related to hypoxia during cerebral aneurysm surgeryxombined microdialysis and tissue oxygen monitoring: case report. Neurosurgery 46, 201-205.
27. IMPERATORE, C., GERMANÒ, A., D'AVELLA, D., et al. (2000). Effects of the radical scavenger AVS on behavioral and BBB changes after experimental subarachnoid hemorrhage. Life Sci. 66, 779-790.
28. INAGE, Y.W., ITOH, M., WADA, K., et al. (2000). Glutamate transporters in neonatal cerebellar subarachnoid hemorrhage. Pediatr. Neurol. 23, 42-48.
29. JACKOWSKI, A., CROCKARD, A., BURNSTOCK, G., et al. (1990). The time course of intracranial pathophysiological changes following experimental subarachnoid hemorrhage in the rat. J. Cereb. Blood Flow Metab. 10, 835-849.
30. JOSHITA, H., KASSELL, N.F., and SASAKI, T. (1990). Blood-brain barrier disturbance following subarachnoid hemorrhage in rabbits. Stroke 21, 1051-1058.
31. KAWAMATA, T., PETERSON, J.W., BUN, T., et al. (1997). Augmentation of both hemolysate-induced contraction and activation of protein kinase C by submaximum activation in canine cerebral arteries in vitro. J. Neurosurg. 87, 908-915.
32. KOIDE, T., GOTOH, O., ASANO, T., et al. (1985). Alterations of the eicosanoid synthetic capacity of rat brain microvessels following ischemia: relevance to ischemic brain edema. J. Neurochem. 44, 85-93.
33. KRIZBAI, I.A., DELI, M.A., PESTENACZ A., et al. (1998). Expression of glutamate receptors on cultured cerebral endothelial cells. J. Neurosci. Res. 54, 814-819.
34. LEPPIK, I.E., and WOLDD, D.L. (1993). Antiepileptic medication interactions. Neurol. Clin. 11, 905-21.
35. MCCABE, R.T., WASTERLAIN, C.G., KUCHARCZYK, N, et al. (1993). Evidence for anticonvulsivant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J. Pharmacol. Exp. Ther. 264, 1248-1252.
36. NILSSON, D.G., SAVELAND, H., BORIS-MOLLER, F., et al. (1996). Increased levels of glutamate in patients with subarachnoid hemorrhage as measured by intreacerebral microdialysis. Acta Neurochir. Suppl. (Wien.) 67, 45-47.
37. NILSSON, D.G., BRANDT, L., UNGERSTEDT, U., et al. (1999). Bedside detection of brain ischemia using intracerebral microdialysis: subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery 45, 1176-1184.
38. ONAL, M.Z., LI, F., TATLISUMAK, T., et al. (1997). Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke 28, 1060-1065.
39. PALMER, K.J., and MCTAVISH, D. (1993). Felbamate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Drugs 45, 1041-65.
40. PAXINOS, G., and WATSON, C. (1982). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
41. PERSSON, L., VALTYSSON, J., ENBLAD, P., et al. (1996). Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J. Neurosurg. 84, 606-616.
42. PETERSON, J.W., ROUSSOS, L., and KWUN, B.D. (1990). Evidence of the role of hemolysis in experimental vasospasm. J. Neurosurg. 72, 775-781.
43. PRUNELL, G.F., MATHIESEN, T., DIEMER, N.H., et al. (2003). Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 52, 165-175.
44. PRUNELL, G.F., MATHIESEN, T., and SVENDGAARD, N.A. (2004). Experimental subarachnoid hemorrhage: cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery 54, 426-436.
45. REKLING, J.C. (2003). Neuroprotective effects of anticonvulsivants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci. Lett. 335, 167-170.
46. RÖSSNER, W., and TEMPEL, K. (1966). Quantitative bestimmung der permeabilität der sogenannten blut-hirnschranke für Evans-Blau (T 1824). Med. Pharmacol. Exp. 14, 169-182.
47. SARRAFZADEH, A.S., UNTEBERG, A.W., and LANKSCH, W.R. (1998). Bedside-microdialysis for early detection of vasospasm after subarachnoid hemorrhage. Case report and review of the literature. Zentralbl. Neurochir. 59, 269-273.
48. SARRAFZADEH, A.S., SAKOWITZ, O.W., and KIENING, K.L. (2002). Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit. Care Med. 30, 1062-1070.
49. SASAKI, T., ASANO, T., and TAKAKURA, K. (1982). Inhibitory effects of drugs on the vasoconstriction induced by the cerebrospinal fluid of SAH, in: Proceedings of the 11th Conference on Surgical Treatment of Stroke. T. Iwabuchi (ed), Neuron-sha: Tokyo, pps. 183-188.
50. SASAKI, T., KASSELL, N.F., and YAMASHITA, M. (1985). Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J. Neurosurg. 63, 433-440.
51. SASAKI, T., KASSELL, N.F., and ZUCCARELLO, M. (1986). Barrier disruption in the major cerebral arteries during the acute stage after experimental subarachnoid hemorrhage. Neurosurgery 19, 177-184.
52. SAVELAND, H., HILLMAN, J., BRANDT, L., et al. (1992). Overall outcome in aneurysmal subarachnoid hemorrhage: a prospective study from neurosurgical units in Sweden during a 1-year period. J. Neurosurg. 76, 729-734.
53. SAVELAND, H., NILSSON, O.G., BORIS-MOLER, F., et al. (1996). Intracerebral microdialysis of glutamate and aspartate in two vascular territories after aneurysmal subarachnoid hemorrhage. Neurosurgery 38, 12-19.
54. SBUAIB, A., WAQAAR, T., IJAZ, M.S., et al. (1996). Neuroprotection of felbamate: a 7- and 28-day study in transient forebrain ischemia in gerbils. Brain Res. 727, 65-70.
55. SCHULZ, M.K., WANG, L.P., TANGE, M., et al. (2000). Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 93, 808-814.
56. SHARP, C.D., HINES, I., HOUGHTON, J., et al. (2003). Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am. J. Physiol. Heart Circ. Physiol. 285, H2592-H2598.
57. SIESJO, B.K. (1992a). Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J. Neurosurg. 77, 169-184.
58. SIESJO, B.K. (1992b). Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J. Neurosurg. 77, 337-354.
59. SMITH, S.L., SCHERCH, H.M., and HALL, E.D. (1996). Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury. J. Neurosurg. 84, 229-233.
60. SODERPALM, B. (2002). Anticonvulsivants: aspects of their mechanisms of action. Eur. J. Pain 6, Suppl A, 3-9.
61. STAUB, F., GRAF, R., GABEL, P., et al. (2000). Multiple interstitial substances measured by microdialysis in patients with subarachnoid hemorrhage. Neurosurgey 47, 1106-1116.
62. SWIADER, M., GASIOR, M., WIESLOZ, M., et al. (2003). Influence of some convulsivant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice. Pol. J. Pharmacol. 55, 649-653.
63. 2+ concentration. Eur. J. Pharmacol. 289, 229-233.
64. UNTEBERG, A.W., SAKOWITZ, O.W., SARRAFZADEH, A.S., et al. (2001). Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J. Neurosurg. 94, 740-749.
65. UYAMA, O., OKAMURA, N., YANASE, M., et al. (1988). Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J. Cereb. Blood Flow Metab. 8, 282-284.
66. R (felbamate). Wallace Laboratories: Cranbury, NJ.
67. WALLIS, R.A., PANIZZON, K.L., FAIRCHILD, M.D., et al. (1990). Felbamate is a potent antihypoxic agent in hippocampal slice. Neurology 40, Suppl. 1, 193.
68. WALLIS, R.A., PANIZZON, K.L., FAIRCHILD, M.D., et al. (1992). Protective effects of felbamate against hypoxia in the rat hippocampal slice. Stroke 23, 547-551.
69. WASTERLAIN, C.G., ADAMS L.M., HATTORI, H., et al. (1992). Felbamate reduces hypoxic-ischemic brain damage in vivo. Eur. J. Pharmacol. 212, 278-278.
70. WASTERLAIN, C.G., ADAMS L.M., WICHMANN, J.K., et al. (1996). Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia. Stroke 27, 1236-1240.
71. YANG, G., CHAN, P.H., BABUNA, O.A., et al. (1994). Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia. Neurosurgery 34, 339-345.
72. YOSHIDA, S., INOH, S., and ASANO, T. (1980). Effect of transient ischemia on free fatty acids and phospholipids in the gerbil brain. Lipid peroxidation as possible cause of postischemic injury. J. Neurosurg. 53, 323-331.
73. ZOUH, D., MAYBERG, M.R., LONDON, S., et al. (1996). Reduction of intracellular glutathione levels produces sustained arterial narrowing. Neurosurgery 39, 991-997.
74. ZUCCARELLO, M., and ANDERSON, D.K. (1989). Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke 20, 367-371.
75. ZUCCARELLO, M., LEWIS, A.I., UPPUTURI, S., et al. (1994). Effect of racemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits. J. Neurotrauma 11, 691-698.